Sen. Sheldon Whitehouse sold Novartis AG (NVS)
Sen. Sheldon Whitehouse (D-RI) · $1K–$15K · traded Apr 9, 2024
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- The member
- Traded
- Apr 9, 2024
- Disclosed
- May 20, 2024
- Days to disclose
- 41
- Asset type
- Stock
- As filed
- Novartis Ag ADR
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- May 20, 2024$1K–$15K
Sold (full) JP MORGAN CHASE & CO Rate/Coupon: 6.12% Matures: 02/12/2056
$1K–$15K · Traded Apr 30, 2024 · disclosed May 20, 2024 · Spouse
- May 20, 2024$1K–$15K
$1K–$15K · Traded Apr 9, 2024 · disclosed May 20, 2024 · Spouse
- May 20, 2024$1K–$15K
$1K–$15K · Traded Apr 9, 2024 · disclosed May 20, 2024 · Spouse
- May 20, 2024$15K–$50K
$15K–$50K · Traded Apr 9, 2024 · disclosed May 20, 2024 · Spouse
- May 20, 2024$15K–$50K
$15K–$50K · Traded Apr 9, 2024 · disclosed May 20, 2024 · Spouse
Recent Congress trades in NVS
- Sep 28, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Aug 27, 2026 · disclosed Sep 28, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Committee overlap: HELP - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP - Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 24, 2025 · Spouse
- Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 24, 2025 · Spouse
- Nov 24, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 24, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (partial) Novartis AG NVS
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 11, 2025 · disclosed Oct 22, 2025 · Spouse
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.